Last reviewed: June 9, 2026
Last updated: June 9, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has become one of the most sought-after weight loss medications, with clinical trials showing an average 15% body weight reduction over 68 weeks. Understanding qualification criteria helps you determine if this GLP-1 therapy matches your health goals. PlexusDx simplifies access to compounded semaglutide injection through licensed 503A pharmacies, eliminating insurance barriers for personalized treatment.
Medical Eligibility Criteria for Semaglutide Treatment
Semaglutide qualification typically requires meeting one of two pathways: a BMI of 30 or higher, or a BMI of 27 or higher combined with weight-related health conditions. Weight-related conditions include type 2 diabetes, hypertension, sleep apnea, or heart disease. Your medical history matters as much as your BMI number when determining candidacy.
PlexusDx evaluates your full clinical profile during the consultation process rather than applying a single rigid threshold. This individualized approach means patients with metabolic concerns, insulin resistance, or family history of obesity-related disease may qualify even at lower BMI ranges. The goal is matching you with a treatment that addresses your specific metabolic needs rather than fitting a standardized formula.
Age also plays a role in semaglutide qualification. Adults aged 18 and older can use semaglutide for weight management, while pediatric use requires specialized dosing protocols. Pre-existing conditions like pancreatitis history, thyroid cancer, or severe kidney disease typically exclude patients from treatment, so honest medical disclosure during your consultation is essential.
BMI Thresholds and Weight-Related Health Conditions
A BMI of 30 qualifies you as clinically obese by standard definitions, making you a candidate for semaglutide monotherapy. However, BMI represents only one piece of your metabolic picture. Someone with a BMI of 27 who has diabetes, high blood pressure, or elevated cholesterol may benefit more from semaglutide than a BMI-30 patient without comorbidities.
Weight-related comorbidities that strengthen your candidacy include cardiovascular disease, metabolic syndrome, fatty liver disease, and reproductive health challenges like PCOS. Each condition reflects underlying insulin resistance or metabolic dysfunction that semaglutide can help address. During consultation, PlexusDx clinicians assess your complete health profile rather than fixating on a single number.
Waist circumference sometimes matters more than BMI for predicting metabolic risk. Men with waist circumference over 40 inches and women over 35 inches show increased cardiovascular and metabolic disease risk. This measurement-based assessment helps identify patients who benefit from semaglutide even when BMI falls in borderline ranges.
PlexusDx Qualification Process: No Insurance Required
PlexusDx removes traditional insurance barriers that prevent qualified patients from accessing semaglutide. You do not need existing coverage, a referral from an insurance company, or approval from a third-party administrator. This streamlined process means you can begin treatment within days rather than waiting weeks for insurance reviews.
The PlexusDx qualification process starts with a comprehensive medical questionnaire covering your weight history, health conditions, medications, and treatment goals. A licensed clinician then reviews your information and may request recent bloodwork or vital signs to ensure semaglutide aligns with your current health status. This personalized review takes the guesswork out of whether you truly qualify.
HSA and FSA accounts cover PlexusDx semaglutide treatment, giving qualified patients tax-advantaged payment options. Patients pay flat monthly rates starting at $149 per month for compounded semaglutide injection through a licensed 503A pharmacy. Your dose may need to go up during your treatment journey, but your price remains consistent—no hidden per-dose escalations or surprise billing.
Genetic Testing for Personalized Semaglutide Response
Beyond standard qualification criteria, PlexusDx offers the Precision Peptide Genetic Test to predict how your body will respond to semaglutide at the molecular level. This test analyzes genetic variants in key pathways: the GLP-1 receptor (GLP1R rs6923761), glucose-dependent insulinotropic polypeptide receptor (GIPR rs1800437), fat mass and obesity-associated gene (FTO rs9939609), and melanocortin-4 receptor (MC4R rs17782313). Understanding your genetic predispositions helps optimize your treatment from day one.
The Precision Peptide Genetic Test maps 14 peptide pathways and 150+ genetic insights relevant to weight management and metabolic health. This information guides clinicians in selecting the most effective dose range and helps predict whether you might benefit from dual-compound therapy like GLP-Squared. Available as a $99 add-on after your first month of treatment, this test transforms standard semaglutide therapy into precision medicine tailored to your biology.
Genetic insights alone do not determine semaglutide qualification, but they enhance your clinical picture once you are eligible. Someone with favorable GLP-1 receptor genetics might achieve impressive results on standard semaglutide, while another patient with reduced receptor sensitivity might benefit more from tirzepatide or combination therapy. PlexusDx uses this information to personalize not just whether you qualify, but how to optimize your specific treatment.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the minimum BMI to qualify for semaglutide at PlexusDx?
PlexusDx qualifies patients with a BMI of 30 or higher, or a BMI of 27 or higher combined with weight-related health conditions like diabetes or hypertension. Individual clinical review means some patients below these thresholds may qualify based on metabolic indicators or comorbidities. Contact PlexusDx to discuss your specific situation with a licensed clinician.
Do I need a doctor's referral to start semaglutide at PlexusDx?
No referral is required. PlexusDx provides direct access through licensed clinicians who conduct a comprehensive medical review. You do not need to navigate insurance approvals or obtain permission from another physician. This streamlined approach means qualifying patients can begin treatment within days.
How much does compounded semaglutide injection cost at PlexusDx?
Compounded semaglutide injection starts at $149 per month through a licensed 503A compounding pharmacy. Your dose may increase during treatment, but your monthly price remains flat. HSA and FSA accounts are eligible, and PlexusDx serves all 50 states without requiring insurance.
Are there medical conditions that disqualify me from semaglutide?
Patients with a personal history of medullary thyroid cancer, multiple endocrine neoplasia type 2, severe pancreatitis, or advanced kidney disease typically cannot use semaglutide safely. Other contraindications include certain medications and pregnancy. PlexusDx clinicians review your full medical history during consultation to identify any safety concerns.
How does the Precision Peptide Genetic Test improve my semaglutide qualification?
The genetic test does not determine initial qualification but refines your personalized treatment plan by analyzing GLP-1 receptor, GIPR, FTO, and MC4R variants. This $99 add-on available after your first month helps PlexusDx clinicians predict your response and adjust dosing strategy. Understanding your peptide pathway genetics transforms standard semaglutide into precision medicine.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is It Safe to Switch from Semaglutide to Tirzepatide?
How to Get GLP-1 Medications with Insurance Coverage